Recalls for Daptomycin for injection

Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter
04/18/2014 Food Recall

(NASDAQ: CBST) today announced it is voluntarily recalling one lot of CUBICINĀ® (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles, found in a single vial from this lot, produced by a contract manufacturer. The administration of glass particulate, if present in an intravenous drug, poses a potential safety risk to patients.

  • Company:
    Cubist Pharmaceuticals, Inc.
  • Problem
    Suffocation And Choking Hazards